Legal marketing tips today center on adapting to digital tools, building a strong brand, using personalized outreach, AI and automation, mobile-first design, valuable content, and data-driven decisions to attract qualified clients and stay competitive. What worked five years ago may already feel outdated, and strategies that dominate today’s search engine results pages (SERPs) may soon […]
Month: July 2026
Mass tort practice growth is one of the most talked-about opportunities in the personal injury world right now. But should your firm actually make the leap? This guide walks you through the economics, operational demands, marketing strategies, and compliance realities so you can make an informed decision-not one driven by hype. Key Takeaways What Mass […]
Mass tort intake is not just a busier version of personal injury intake. It is a fundamentally different discipline that demands its own systems, staffing, and strategic thinking. If your firm is ready to grow through mass tort litigation, the intake process will determine whether your marketing dollars generate signed cases or just noise. Why […]
The mass tort landscape is shifting fast. If your firm handles personal injury work, the opportunities unfolding across pharmaceutical, environmental, and technology-driven dockets right now could define your caseload for the next several years. Here is what you need to know about the most consequential mass tort cases in 2026 and how to position your […]
Mass tort leads are potential plaintiffs who have suffered similar harm from a common source, whether a defective drug, a faulty medical device, or environmental contamination. In the current competitive landscape, the demand for mass tort leads has surged in recent years, and law firms across the country are deciding whether to buy mass tort […]
Introduction: Why Mass Tort Marketing Matters for Growing PI Firms If your firm handles personal injury cases and you’re looking to scale, mass tort marketing deserves serious attention. A mass tort involves many plaintiffs who suffered similar injuries from the same product, pharmaceutical, medical device, or toxic exposure. Think Roundup cancer claims, the Zantac lawsuit […]
California’s rideshare liability landscape is evolving rapidly. Following SB 371 and the recent June 2026 agreement between Uber and the Consumer Attorneys of California (CAOC) to settle the Uber ballot measure dispute, personal injury attorneys face a new environment that requires updated strategies for intake, case valuation, and marketing. Here is what you need to […]
Key Takeaways Introduction: Why SB 623 Matters for California Personal Injury Case Valuation SB 623 is a California bill working through the 2025–2026 legislative session, heavily supported by Uber, Lyft, and insurance-aligned interests. Its stated goal is to curb “inflated medical bills” and lower auto insurance premiums. In practice, the bill would limit the medical […]
Core Provisions of SB 623: A Brief Overview of What Existing Law Requires Introduction: Why the Rideshare Provisions of SB 623 Matter Most for the Attorney or Law Firm PI Firms California’s SB 623 designation covers three separate legislative efforts, but the pending rideshare safety and liability reforms stand to have the greatest direct impact […]